“seres-therapeutics” Archives

in
Entry Author Date Location
Seres Dissects Failed Microbiome Drug Trial, Suggests Changes to FDA 01/31/17 Boston
With $19M, Axial Becomes Latest Startup to Target Gut-Brain Connection 11/30/16 Boston
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Pronutria, Eyeing Clinical Push, Gets $42.5M From Nestle Health 02/23/16 Boston
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
Seres Inks Nestlé As Potential $2B Partner; Key Microbiome Data Soon 01/11/16 Boston
With Startup, Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again 12/10/15 New York
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
Boston’s Life Science Disruptors 2015: The Photos 10/06/15 Boston
Five Takeaways From “Boston’s Life Science Disruptors” 10/02/15 Boston
Agenda Posted for Boston’s Life Science Disruptors on Sept. 30 09/22/15 Boston
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30 09/14/15 Boston
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO 06/25/15 Boston
On Eve of Seres IPO, A Rival Nonprofit Microbiome Treatment Expands 06/25/15 Boston
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
Gold Bugs? Seres Files For First IPO of Human Microbiome Era 05/27/15 Boston
Page 2 of 2 « previous page